Zonegran Capsule
Product Images NDC 59212-681

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zonegran (NDC 59212-681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanz Pharma (us) Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg

100mg
Label for Zonegran (zonisamide) 100 mg capsules, containing 100 capsules. The label includes storage instructions, dosage note to see prescribing information, and distributor info (Amdipharm Limited, Dublin, Ireland). It features the Concordia Pharmaceuticals logo and states it is Rx only and made for Concordia Pharmaceuticals by Advanz Pharma (US) Corp.*
FDA Label Image

25mg

25mg
The packaging label for Zonegran capsules contains 25 mg of the active ingredient zonisamide. The label indicates a count of 100 capsules and includes storage instructions to keep at 25°C (77°F) with permitted excursions to 15-30°C (59-86°F). It is labeled for prescription use only and manufactured for Concordia Pharmaceuticals by Amdipharm Limited in Dublin, Ireland. The label also highlights the necessity to dispense an accompanying medication guide to patients.*
FDA Label Image

Zonegran-01 (Zonegran 1)

Zonegran-01 (Zonegran 1)
Chemical structure of zonisamide, the active ingredient in Zonegran. The diagram shows the molecular structure with a benzisoxazole core and a sulfonamide side group.*
FDA Label Image

Zonegran-02 (Zonegran 2)

Zonegran-02 (Zonegran 2)
A plot showing the percentage reduction in all partial seizures rate by patient percentage comparing treatment arms. The graph compares Zonegran (blue dots) versus Placebo (orange diamonds), showing improvement, no change, or worsening in seizures across patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.